Search the full ICD-10 catalog by:
lithium R78.89 (abnormal level) specified substance NEC R78.89 Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
When a diagnostic test is ordered in the absence of signs/symptoms or other evidence of illness or injury, the testing facility or the physician interpreting the diagnostic test should report the screening code as the primary diagnosis code. Any condition discovered during the screening should be reported as a secondary diagnosis.
89.
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
83.
Z51. 81 Encounter for therapeutic drug level monitoring - ICD-10-CM Diagnosis Codes.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79. 899—Other Long Term (Current) Drug Therapy.
Therapeutic drug monitoring (TDM) is testing that measures the amount of certain medicines in your blood. It is done to make sure the amount of medicine you are taking is both safe and effective. Most medicines can be dosed correctly without special testing.
Long term (current) drug therapy Z79-
ICD-10 Code Z79. 4, Long-term (current) use of insulin should be assigned to indicate that the patient uses insulin for Type 2 diabetes mellitus (Category E11* codes). Z79. 4 should NOT be used for Type 1 diabetes mellitus (Category E10* codes).
A: Assign a code from Z79 if the patient is receiving a medication for an extended period as a prophylactic measure (such as for the prevention of deep vein thrombosis) or as treatment of a chronic condition (such as arthritis) or a disease requiring a lengthy course of treatment (such as cancer).
Z03. 89 No diagnosis This diagnosis description is CHANGED from “No Diagnosis” to “Encounter for observation for other suspected diseases and conditions ruled out.” established. October 1, 2019, with the 2020 edition of ICD-10-CM.
V58. 69 - Long-term (current) use of other medications. ICD-10-CM.
Quantitation of detected drugs is not reimbursable. Code 82205 is for therapeutic monitoring only.
F90. 1, Attention-deficit hyperactivity disorder, predominantly hyperactive type.
01 Long term (current) use of anticoagulants.
ICD-Code E03. 9 is a billable ICD-10 code used for healthcare diagnosis reimbursement of Hypothyroidism, Unspecified.
THAYR-uh-pee) Treatment with any substance, other than food, that is used to prevent, diagnose, treat, or relieve symptoms of a disease or abnormal condition.
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code Z51.81:
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code (s). The following references for the code Z51.81 are found in the index:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
Z51.81 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG).
Immunoassay (IA) • Inductively Coupled Plasma/Mass Spectrometry (ICP/MS) • Spectrometry • Spectrophotometry (SP)
Serum separator (gel barrier) tubes • EDTA plasma • No lithium containing anticoagulants
Ordering Restrictions may apply. Please provide SERVICE AREA INFORMATION to find available tests you can order.
Lithium as lithium carbonate is used as a psychoactive agent in the treatment of manic depressive disorders. Lithium therapy demands daily monitoring of serum lithium levels until the proper dose schedule is determined.
Lithium is completely absorbed six to eight hours after oral administration. Since the onset of action is slow (5 to 10 days), parenteral administration is of no advantage. The plasma half-life is 17 to 36 hours, and this drug is eliminated almost entirely by the kidneys.
Lithium affects the cardiac conduction system by incomplete substitution for other cations, especially sodium and potassium. These electrolyte changes account for the usually unimportant and reversible T-wave depressions observed in 10% to 20% of patients on lithium therapy.
Since lithium works intracellularly, the erythrocyte concentration of the drug may be more relevant than levels in serum; therefore, in unresponsive patients, doses that produce higher than usual serum concentrations can be used if erythrocyte concentrations are lower.
It is advisable to perform periodic plasma sodium determinations. Low plasma sodium levels are associated with lithium retention; high levels with lithium elimination. Varying degrees of nephrogenic diabetes insipidus have been reported to occur in 33% of lithium treated patients.
Lithium interferes with solute and water absorption from the gastrointestinal system producing nausea, vomiting, diarrhea, and abdominal pain. These symptoms may occur at any time, at any serum level. They most commonly occur during early treatment stages and usually clear spontaneously or by adjustment of dosage.
Lithium ion is not protein bound, is distributed in total body water, and is concentrated in various tissues to different degrees. After a steady-state has been achieved, the lithium level in cerebrospinal fluid is about 40% of that in serum, and renal clearance for an individual remains relatively constant.
A Code Also note indicates that two or more codes may be required to fully describe a condition, but the order of codes is at the coder's discretion. Code order depends on the severity of the conditions and the reason for the encounter.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code Z51.81. Click on any term below to browse the alphabetical index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code V58.83 was previously used, Z51.81 is the appropriate modern ICD10 code.